Form 4: Immunovant CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Immunovant CEO Peter Salzmann sold shares to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Immunovant's CEO, Peter Salzmann, sold shares of common stock on August 21, 2024, to cover tax obligations.
- The sales were mandated by Immunovant's policy to cover tax withholding obligations through 'sell to cover' transactions.
- A total of 14,470 shares were sold at a weighted average price of $31.84, and 598 shares were sold at a weighted average price of $32.32.
- Following these transactions, Salzmann still beneficially owns 1,008,344 shares of Immunovant common stock.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (sale of shares to cover taxes) by the CEO. It's neutral in tone and doesn't indicate any significant positive or negative developments for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among executives in publicly traded companies. This ensures compliance with tax laws and allows executives to manage their equity compensation effectively.
Key Dates
| Date | Description |
|---|---|
| 08/17/2022 | Holder was granted 451,264 restricted stock units |
| 08/17/2024 | 28,204 restricted stock units vested |
| 08/21/2024 | CEO sold shares to cover tax obligations |
| 08/23/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.